Winners ECNP Excellence Awards 2021

P.0003
Anti-inflammatory antibiotic Minocycline: brain deliveryand downregulation of voluntary alcohol intake in rats
Petr Anokhin, Russian Federation

P.0024
Changes in NMDA receptor subunit composition accompanies the hypoxia-induced plasticity of the excitatory retinocollicular neurotransmission
Hanna Dumanska, Ukraine

P.0031 
Prevalence of anxiety disorders included in The Mini-International Neuropsychiatric Interview (M.I.N.I.) among the general population of Latvia in 2019-2020
Viktorija Vineta Vinogradova, Latvia

P.0041 
Effects of environmental enrichment on the behavioral and structural alterations in rats prenatally exposed to valproic acid
Lali Kruashvili, Georgia

P.0061 
Ketamine affects expression of Itgb3, Itgav, Chl1 and Sirt1 in the prefrontal cortex of rats in a depressive-like behaviour model
Vesna Pesic, Serbia

P.0076 
Evaluation of the staging after the first manic episode in patients with bipolar disorder
Vefa Erbasan, Turkey

P.0077 
Higher systemic oxidatively generated DNA and RNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
Klara Coello, Denmark

P.0078 
Inflammatory cytokine plasma levels correlation with MADRS score in patients with treatment-resistant major depression after dry-powder inhaled esketamine administration
Mikolaj Matłoka, Poland

P.0081 
The evaluation of cardiovascular risk through aterogenic index during manic, depressive and mixed episodes of bipolar disorder
Suat Yalcin, Turkey
 
P.0111 
Altered nitric oxide concentration as the potential link between nitric oxide synthase genetic variation and mental illness pathogenesis
Rhiannon McNeill, Germany

P.0120 
Childhood adversities and the comorbidity between mood and general medical disorders in adults
José Oliveira, Portugal

P.0128 
The Increased dynamic functional network reconfiguration in cognitively declining multiple sclerosis patients
Tommy Broeders, The Netherlands

P.0144
Her pain is not his pain, sex differences in migraineurs’ periaqueductal gray matter functional connectivity
Kinga Gecse, Hungary

P.0157 
Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens First-Episode Psychosis Research Study
Gamze Erzin, Turkey

P.0170
Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ
Laura Ferraro, Italy

P.0177 
Partial ornithine-transcarbamylase deficiency, autoimmunity and psychosis – a complex case report
Gabriela Raluca Marinescu, Romania

P.0209 
Nonpsychotic psychiatry impairments in early age children with developmental language delay
Alena Leonova, Russian Federation

P.0243 
Propionate-induced activation of autophagy in ventromedial hypothalamic neurons of rats with type 2 diabetes mellitus
Maksym Shanchuk, Ukraine

P.0245 
Truncated form of TrkB receptor (TrkB.T1) overexpression in the hippocampus affected behavior and expression of neuroplasticity-related genes in mice
Tatiana Ilchibaeva, Russian Federation
 
P.0248
Role of trace amine-associated receptor 5 (TAAR5) in the regulation of dopamine transmission and adult neurogenesis
Raul Gainetdinov, Russian Federation

P.0251
The Influence of the A2A antagonist KW6002 on dopaminergic system, motor functioning and neuroinflammation in a rodent model of Parkinson’s disease
Kavya Prasad, The Netherlands

P.0256
Protective effect of propionic acid on impairments of astrocyte-microglia crosstalk in ventromedial hypothalamus of rats with type 2 diabetes mellitus
Nataliia Shulha, Ukraine

P.0260 
Optimising a human induced pluripotent stem cell system to model the effects of il-6 on early neurodevelopment
Amalie Couch, United Kingdom

P.0276
Cellular and molecular signatures of in vivo GABAergic neurotransmission in the human brain
Paulina Lukow, United Kingdom

P.0305 
Investigating the effects of CYP2C19*2 genetic polymorphisms on the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome
Valentin Skriabin, Russian Federation

P.0319 
Clonidine lowers Interleukin-6 in people with HIV during opioid withdrawal
Vladimir Palatkin, Russian Federation

P.0344 
The use of allogeneic human umbilical cord blood cells in children with autism: the effectiveness and safety of the method
Daria Emelina, Russian Federation

P.0351 
The Amygdala connectivity as a mediator between common genetic background for autism and social functioning
Giorgia Bussu, The Netherlands

P.0358 
Synergistic anticonvulsant effect of carbamazepine and mono-/bicyclic terpenoids on pentylenetetrazole-induced seizures
Mariia Nesterkina, Ukraine

P.0361
The Abnormal white-matter rich-club organization in obsessive-compulsive disorder
Samantha Baldi, The Netherlands

P.0362 
Transcriptome-wide association study of treatment-resistant depression for drug repurposing
Chiara Fabbri, Italy

P.0363 
Relevance of immunometabolic status for the evaluation of cognitive performance in patients with major depressive disorder
Yolanda Sánchez-Carro, Spain

P.0365 
Associations between abnormal brain function during emotion processing and lifetime disease course in major depressive disorder
Hannah Lemke, Germany

P.0399 
Differential subcortical volume in patients with major depressive disorder and healthy controls depending on patterns of adverse childhood experiences
Lena Waltemate, Germany

P.0404 
Rapid antidepressant response to first-line selective serotonin reuptake inhibitors in post-COVID-19 depression
Mario Gennaro Mazza, Italy

P.0405
Enhanced inflammatory response in the brain of suicide victims is associated with a weakening of the AMPK/CREB signaling pathway
Magdalena Sowa-Kućma, Poland

P.0413 
Modifiable risk and protective factors influencing changes in subjective depression during the COVID-19-lockdown: identifying targets for prevention and intervention
Lívia Priyanka Elek, Hungary

P.0422
CLOCK gene variation mediates effect of early childhood adversities and recent stressors on current depressive symptoms
Dorka Győrik, Hungary

P.0457
Effect of clozapine on suicidality in patients with schizophrenia
Gamze Gürcan, Turkey

P.0491 
NREM sleep upregulates human brain pulsation detected by Ultrafast Magnetic Resonance Encephalography
Sara Marie Ulv Larsen, Denmark

P.0498 
Social isolation in adolescence and long-term changes in the gut microbiota composition
Nicola Lopizzo, Italy

P.0505 
Modulation of n-acylethanolamines restores the cognitive deficits induced by early alcohol exposure
Alba Garcia, Spain
 
P.0515
Amygdala size associates with stress perception
Inês Caetano, Portugal

P.0520 
Transcranial magnetic stimulation (TMS) for the treatment of pharmacotherapy resistant auditory hallucinations (AH) in patients with schizophrenia
Igor Potapov, Russian Federation

P.0542 
Neuronal activity in the amygdala as response to positive and negative emotional memory formed in daily agonistic interactions
Dmitriy Smagin, Russian Federation

P.0546 
Inhibition of basal amygdala-nucleus accumbens glutamate neurons reduce reward learning and motivation in mice
Lorraine Madur, Switzerland

P.0548 
Tryptophan hydroxylase 2 deficiency modifies the effects of chronic fluoxetine treatment on the brain serotonin system and behavior in zebrafish
Valentina Evsiukova, Russian Federation

P.0555 
Vitamin D3 ameliorates memory functions in rats with scopolamine-induced memory decline
Hristina Zlatanova, Bulgaria

P.0563 
Depletion of 25-hydroxyvitamin D circulating pool and derangement of receptor activator of NF-κB/osteoprotegerin axis are involved in glucocorticoid-induced brain injury
Olha Lisakovska, Ukraine

P.0568 
Antidiabetic medications and risk of depression – a nested case-control study
Ida Kim Wium-Andersen, Denmark

P.0576 
Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice
Dmitry Eremin, Russian Federation

P.0580 
A polygenic risk score predicts an increased risk of depression in mentally healthy young adults
Anastasiya Kazantseva, Russian Federation
 
P.0598 
Priapism associated with antiepileptic drugs: a disproportionality analysis in the Food and Drug Administration’s Adverse Event Reporting System
Ana Pejcic, Serbia

P.0603 
The antimicrobial effects of mirtazapine and fluvoxamine: results of the pilot experiment
Grigory Rukavishnikov, Russian Federation

P.0610 
Dopamine D3 Receptor antagonism in alcohol dependence: A case-control functional Imaging study
Rayyan Raja Zafar, United Kingdom

P.0622 
Cue-reactivity task in patients with alcohol use disorder
Nathalie Rieser, Switzerland

P.0642 
The apelinergic system influences anxiety-like behavior in a mouse model of comorbidity between diabetes and depression
Sébastien Bullich, France

P.0655
The sensory profile of Nrxn1α gene knockout mice based on local field potentials
Freja Gam Østergaard, The Netherlands

P.0670 
Shaped before birth: obstetric complications identify a more severe clinical phenotype among patients presenting an affective or non-affective first-episode psychosis
Maria Sagué-Vilavella, Spain

P.0677 
Fronto-limbic functional connectivity associated with childhood maltreatment in adults with depression
Janik Goltermann, Germany

P.0681 
Dipyridamole and calcium channel blockers in the treatment of bipolar disorder – a nationwide cohort study
Jonne Lintunen, Finland

P.0687
Safety assessment of esketamine administered via dry powder inhaler in patients with treatment-resistant major depression
Sylwia Janowska, Poland

P.0689 
Reduced cortico-limbic habituation identifies bipolar depressed suicide attempers: a machine learning study
Federico Calesella, Italy

P.0692
Oral contraceptives and the serotonin 4 receptor in major depressive disorder: results from the NeuroPharm 1 study
Soren Vinther Larsen, Denmark

P.0693
Escitalopram: Drug monitoring for dose titration? Systematic literature review on the therapeutic and the dose-related reference range
Luzie Eichentopf, Germany

P.0696 
Nuclei RNAseq reveals transcriptional alterations of prefrontal cortex astrocytes in a subpopulation of suicide completers
Michał Ślęzak, Poland

P.0718 
High levels of peripheral neuroinflammatory markers are associated with disruption of white matter integrity in patients with major depressive disorder
Camilla Di Pasquasio, Italy

P.0720 
Cognition Assessment in Virtual Reality: Training of real-life cognitive functions with fully immersive virtual reality in mood or psychotic disorders
Andreas Jespersen, Denmark

P.0761
Current suicidal behavior in first-episode psychosis: may inflammatory markers discriminate from non-psychotic suicides?
Meltem Sen, Turkey

P.0766 
Sex differences in hippocampal subfield volumes and relationship to testosterone measures in schizophrenia and bipolar disorders
Claudia Barth, Norway

P.0780 
Threat-based mechanisms underlying psychosis associated with developmental trauma: a behavioural study
Paul Gu-Yun Jung, United Kingdom

P.0816
How social media big data can improve population-based suicide prevention
Anastasia Peshkovskaya, Russian Federation

P.0833 
Neural correlates of pharmacologically and non-pharmacologically induced altered states of consciousness
Flora Moujaes, Switzerland

P.0846 
CMS-induced anhedonic behavior in rats is associated with changes in NMDA and AMPA receptors trafficking in the frontal cortex
Ewelina Sujkowska, Poland

P.0847
Acute genetic depletion of brain serotonin contributes to dominant behaviour and changes in ultrasonic vocalisation in rats
Joanna Gołębiowska, Poland

P.0850 
Different dopamine responses in female rats with aggressive and defensive stress coping
Vsevolod Nemets, Russian Federation

P.0855
Alterations in behavior, neurochemistry and adult neurogenesis in trace amine associated receptor 2 knockout mice
Mikael Mor, Russian Federation

P.0861 
Exploitation of in-vitro and in-vivo models characterized by enhancement of astrocytes upon noradrenergic targeting for study of presymptomatic Parkinson’s disease
Justyna Barut, Poland
 
P.0872 
The association between childhood trauma discordance and suicide ideation among monozygotic and dizygotic twins
Lotta-Katrin Pries, The Netherlands

P.0877 
Lithium treatment influences blood transcriptome during manic but not depressive episode in bipolar patients
Aleksandra Szczepankiewicz, Poland

P.0884
Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from an antidepressant treatment trial
Jan Engelmann, Germany

P.0906 
The effects of aging and cerebral serotonin deficiency on brain and liver cytochrome P450 2D in female rats – sex differences
Anna Haduch, Poland

P.0907 
Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia
Paula Unzueta-Larrinaga, Spain